J
Jyss Bio
Single-use bioreactors and bioprocessing solutions for pharmaceuticals
About Jyss Bio
Zhejiang Jyss Bio-Engineering Co., Ltd. (Jyss Bio) is a high-tech enterprise founded in 2014 that localizes single-use bioreactors and assemblies for the biopharmaceutical industry in China. The company provides comprehensive technological solutions for the entire biopharmaceutical process, from research and development to industrialization. Its offerings cater to pharmaceutical production and R&D institutions involved with antibody drugs, vaccines, gene therapy, and cell therapy.
The company's product portfolio is centered around its core single-use bioreactors, which feature a patented, non-bubbling oxygen transfer mechanism designed for high efficiency and low shear force, enabling high-density cell cultivation. Beyond bioreactors, Jyss Bio develops and manufactures a wide array of single-use consumables and equipment for the entire bioprocess workflow. This includes products for cell culture, fluid management, purification, and filtration. Specific products include various bioreactor models (stirred, torrent, wave-mixed), magnetic mixing systems, sterile tube welders and sealers, chromatography systems, and single-use storage, mixing, and sampling bags.
Founded in Hangzhou, China, Jyss Bio operates multiple facilities, including GMP-compliant production workshops for consumables and bioreactors in Hangzhou and Huzhou, and a manufacturing base in Shanghai for downstream equipment. The company has received significant venture capital backing, completing Series A, B, and B+ funding rounds in 2021 and 2022 to expand production capacity and accelerate R&D. Key investors include Huatai International, CICC Capital, and Sinovac. As part of its growth, Jyss Bio has expanded its product lines into downstream purification with chromatography and ultrafiltration systems to provide integrated upstream and downstream solutions. The company was recognized for its contribution during the COVID-19 pandemic by CanSino Bio and has received industry awards such as the "2021 Best IVD and Life Science Enterprise Award".
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Hangzhou, China
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 25.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jan 2022 | $28M | $110M | Zhongjin Qiyuan Investment · CICC · Kexing Holdings · Huatai Securities | ↗ |
| SERIES BOther financing | Jul 2021 | $28M | $110M | Sherpa Invest · CMB International · CITIC Medical · Huatai Securities | — |
Growth signals
Latest recorded traffic for Jyss Bio is 1.9K monthly website visits, down 5% over the last three months. Jyss Bio's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Huatai Securities
CMB International Capital
Sherpa Invest- CICMB International
CITIC Medical- ZIZhongjin Qiyuan Investment
CICC- KHKexing Holdings
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jyss Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jyss Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







